CDTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Cidara Therapeutics, Inc. is Fair to Shareholders

Core Viewpoint - The law firm Halper Sadeh LLC is investigating the fairness of the sale of Cidara Therapeutics, Inc. to Merck for $221.50 per share in cash, focusing on the interests of Cidara shareholders [1]. Group 1 - Halper Sadeh LLC is an investor rights law firm conducting an investigation regarding the sale of Cidara Therapeutics [1]. - The sale price of $221.50 per share in cash is under scrutiny to determine its fairness to Cidara shareholders [1]. - Cidara shareholders are encouraged to explore their legal rights and options related to the sale [1].